ReviewPublished 25 September 2026CLDN18 and FGFR2 splicing variants are emerging tumor-associated antigens for cancer therapyMasuko Katoh · Masaru KatohFrontiers in Molecular Medicinedoi 10.3389/fmmed.2026.1927389
Case ReportPublished 15 July 2026Case Report: Alternative biopsy targets plus CEUS-guided omental puncture: enabling CLDN18.2 detection and precision therapy enrollment in pancreatic cancerHang Yin · Xiaomeng Zhang · Bing Song · Hui Li · Kun Liu · Chengzheng ZhangFrontiers in Radiologydoi 10.3389/fradi.2026.1800543
Molecular MedicinePublished 14 October 2025Antibody-drug conjugates targeting the cadherin, claudin and nectin families of adhesion moleculesMasuko Katoh · Yohann Loriot · Izuma Nakayama · Akinobu Hamada · Kohei Shitara · Masaru KatohFrontiers in Molecular Medicinedoi 10.3389/fmmed.2025.1661016
